IL6 and neoplasm: Of particular interest is the enrichment of M0 and M2 macrophages, which resonates with a seminal study demonstrating that radiotherapy induces a distinct, PD‐L1+ tumor‐associated myeloid subset that co‐upregulates protumorigenic factors (IL‐6, CXCL8) and immune checkpoints.